TrendPulse

Johnson & Johnson Says FDA Approves TECNIS PureSee IOL For Cataract Surgery In U.S.

Source: nasdaq FinanceView Original
financeMarch 12, 2026

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA Markets JNJ Johnson & Johnson Says FDA Approves TECNIS PureSee IOL For Cataract Surgery In U.S. March 12, 2026 — 08:25 am EDT Written by RTTNews.com for RTTNews -> (RTTNews) - Johnson & Johnson (JNJ) announced Thursday U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) intraocular lens (IOL) intended for use in cataract surgery. The approval of the TECNIS PureSee IOL gives surgeons an important new lens option. TECNIS PureSee IOL delivers clarity of vision for patients, with 97% of them reporting no very bothersome visual disturbances. TECNIS PureSee IOL will be available for patients in the U.S. later this year. Cataracts naturally form as the eye ages, making everyday activities such as reading, driving, and recognizing faces more difficult. Cataract surgery is one of the safest and most commonly performed procedures worldwide. In a single procedure, TECNIS PureSee IOL addresses both cataract-related vision loss and the effects of presbyopia, which occurs when your eyes gradually lose the ability to see objects clearly up close. TECNIS PureSee IOL is built on the industry-leading TECNIS platform, combining advanced optics with proprietary material. TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL with no warning on loss of contrast sensitivity. TECNIS PureSee IOL is approved globally, and nearly half a million eyes worldwide have already experienced clearer, uninterrupted vision with TECNIS PureSee IOL after cataract surgery. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags Markets RTTNews Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges. More articles by this source -> Stocks mentioned JNJ More Related Articles This data feed is not available at this time. Data is currently not available • Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Johnson & Johnson Says FDA Approves TECNIS PureSee IOL For Cataract Surgery In U.S. | TrendPulse